We are live on ! Find out more
USNA icon

Usana Health Sciences

140 hedge funds and large institutions have $693M invested in Usana Health Sciences in 2016 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 41 increasing their positions, 55 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $567M → $693M (+$126M)

0.93% less ownership

Funds ownership: 85.04%84.1% (-0.93%)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

1% less funds holding

Funds holding: 142140 (-2)

25% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 55

Holders
140
Holders Change
-2
Holders Change %
-1.41%
% of All Funds
3.74%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
41
Reduced
55
Closed
20
Calls
Puts
Net Calls
Net Calls Change

USNA Hedge Fund Activity: Q3 2016 in Review

140 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2016, worth a combined $693M — up 22% from $567M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of USNA and 19 opened new positions — a net loss of 1 holder — while 55 trimmed existing stakes and 41 added.

The largest buyer was Nordea Investment Management, adding an estimated $19.1M. The largest seller was Schroder Investment Management Group, cutting an estimated $9.7M.

  • 140 institutional investors held Usana Health Sciences (USNA) as of Q3 2016, down from 142 in Q2 2016.
  • Funds reported $693M of Usana Health Sciences stock for Q3 2016, up 22% quarter-over-quarter.
  • 19 funds opened new Usana Health Sciences positions in Q3 2016 and 20 closed out, a net change of -1 holder.
  • The largest Usana Health Sciences buyer in Q3 2016 was Nordea Investment Management, an estimated $19.1M added.
  • The largest Usana Health Sciences seller in Q3 2016 was Schroder Investment Management Group, an estimated $9.7M sold.

Based on aggregated 13F filings for Q3 2016.